A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00309179
Recruitment Status : Completed
First Posted : March 31, 2006
Last Update Posted : September 14, 2017
Information provided by (Responsible Party):
Eisai Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 14, 2009
  Actual Study Completion Date : February 13, 2017
  Certification/Extension First Submitted : April 11, 2016